The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a population-based study.


Journal

The British journal of dermatology
ISSN: 1365-2133
Titre abrégé: Br J Dermatol
Pays: England
ID NLM: 0004041

Informations de publication

Date de publication:
03 2019
Historique:
accepted: 10 10 2018
pubmed: 18 10 2018
medline: 25 2 2020
entrez: 18 10 2018
Statut: ppublish

Résumé

Recent studies have shown an increasing incidence of cutaneous adnexal carcinomas (CACs). The aim of our study was to evaluate incidence and survival for cases of CACs and investigate their association with other skin neoplasms. We conducted a population-based study. Data on incident cases of CACs were obtained from the Tuscany Cancer Registry between 1985 and 2010. In order to determine whether the occurrence of squamous cell carcinoma (SCC) among patients with CAC is higher or lower than expected in the general population, the standardized incidence ratio (SIR) was calculated. A total of 242 patients with CAC were observed; the age-standardized incidence rate was 3·8 cases per million person-years. From 1997 to 2010 crude incidence rates increased by 159%. Age-specific incidence was higher in men over 80 years old than in women of the same age and younger individuals. Carcinomas of sweat gland origin prevailed; the most common histotype was porocarcinoma and the most frequently affected site was the head/neck. Overall, 88% of CACs were diagnosed at a localized stage. The 5-year overall survival and disease-specific survival rates were 59% [95% confidence interval (CI) 53-65] and 94% (95% CI 91-98), respectively. In the observation cohort, the number of SCCs was significantly higher than expected as the SIR was calculated to be 33·7 (P < 0·001). Increasing incidence warrants awareness and early diagnosis of CACs. Increased SCC incidence among patients with these tumours highlights the relevance of careful skin examination and follow-up.

Sections du résumé

BACKGROUND
Recent studies have shown an increasing incidence of cutaneous adnexal carcinomas (CACs).
OBJECTIVES
The aim of our study was to evaluate incidence and survival for cases of CACs and investigate their association with other skin neoplasms.
METHODS
We conducted a population-based study. Data on incident cases of CACs were obtained from the Tuscany Cancer Registry between 1985 and 2010. In order to determine whether the occurrence of squamous cell carcinoma (SCC) among patients with CAC is higher or lower than expected in the general population, the standardized incidence ratio (SIR) was calculated.
RESULTS
A total of 242 patients with CAC were observed; the age-standardized incidence rate was 3·8 cases per million person-years. From 1997 to 2010 crude incidence rates increased by 159%. Age-specific incidence was higher in men over 80 years old than in women of the same age and younger individuals. Carcinomas of sweat gland origin prevailed; the most common histotype was porocarcinoma and the most frequently affected site was the head/neck. Overall, 88% of CACs were diagnosed at a localized stage. The 5-year overall survival and disease-specific survival rates were 59% [95% confidence interval (CI) 53-65] and 94% (95% CI 91-98), respectively. In the observation cohort, the number of SCCs was significantly higher than expected as the SIR was calculated to be 33·7 (P < 0·001).
CONCLUSIONS
Increasing incidence warrants awareness and early diagnosis of CACs. Increased SCC incidence among patients with these tumours highlights the relevance of careful skin examination and follow-up.

Identifiants

pubmed: 30328107
doi: 10.1111/bjd.17321
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

565-573

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018 British Association of Dermatologists.

Auteurs

V De Giorgi (V)

Division of Dermatology, University of Florence, Florence, Italy.
Cancer Research "Attilia Pofferi" Foundation, Pistoia, Italy.

L Salvati (L)

Division of Dermatology, University of Florence, Florence, Italy.

A Barchielli (A)

Clinical Epidemiology, Institute for Study and Cancer Prevention, Florence, Italy.

A Caldarella (A)

Clinical Epidemiology, Institute for Study and Cancer Prevention, Florence, Italy.

A Gori (A)

Cancer Research "Attilia Pofferi" Foundation, Pistoia, Italy.

F Scarfì (F)

Division of Dermatology, University of Florence, Florence, Italy.

I Savarese (I)

Division of Dermatology, University of Florence, Florence, Italy.

N Pimpinelli (N)

Division of Dermatology, University of Florence, Florence, Italy.

C Urso (C)

Dermatopathology Study Centre of Florence, Florence, Italy.

D Massi (D)

Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH